Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 2.24% vs 22.66% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -18.77% vs 46.23% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 29.81% vs 28.25% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -21.16% vs 66.00% in Mar 2024
Compare Profit and Loss Results of Anuh Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
661.00
79.00
582.00
736.71%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
661.00
79.00
582.00
736.71%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
0.00
-2.00
0%
Raw Materials Consumed
501.00
35.00
466.00
1,331.43%
Power & Fuel Cost
12.00
0.00
12.00
0%
Employee Cost
23.00
9.00
14.00
155.56%
Operating Expenses
28.00
2.00
26.00
1,300.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
10.00
0.00
10.00
0%
Cost of Software developments
0.00
1.00
-1.00
-100.00%
Miscellaneous Expenses
19.00
0.00
19.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
599.00
53.00
546.00
1,030.19%
Operating Profit (PBDIT) excl Other Income
61.00
25.00
36.00
144.00%
Other Income
9.00
2.00
7.00
350.00%
Operating Profit (PBDIT)
70.00
28.00
42.00
150.00%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
69.00
28.00
41.00
146.43%
Depreciation
8.00
1.00
7.00
700.00%
Profit Before Taxation & Exceptional Items
61.00
26.00
35.00
134.62%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
61.00
26.00
35.00
134.62%
Provision for Tax
13.00
6.00
7.00
116.67%
Profit After Tax
47.00
19.00
28.00
147.37%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
156.00
29.00
127.00
437.93%
Profit Available for appropriations
203.00
49.00
154.00
314.29%
Appropriations
203.00
49.00
154.00
314.29%
Equity Dividend (%)
30%
15%
15.00
Earnings Per Share
9.45
33.75
-24.30
-72.00%
Profit And Loss - Net Sales
Net Sales 661.51 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 2.24% vs 22.66% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 61.53 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -18.77% vs 46.23% in Mar 2024
Profit And Loss - Interest
Interest 1.24 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 29.81% vs 28.25% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 47.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -21.16% vs 66.00% in Mar 2024
